A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).

[1]  M. Josleyn,et al.  Construction and Nonclinical Testing of a Puumala Virus Synthetic M Gene-Based DNA Vaccine , 2012, Clinical and Vaccine Immunology.

[2]  J. Hooper,et al.  DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS) , 2012, PloS one.

[3]  C. Schmaljohn,et al.  A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome. , 2012, Vaccine.

[4]  C. Crandall,et al.  Extracorporeal membrane oxygenation support improves survival of patients with Hantavirus cardiopulmonary syndrome refractory to medical treatment. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  C. Schmaljohn,et al.  A DNA Vaccine for Venezuelan Equine Encephalitis Virus Delivered by Intramuscular Electroporation Elicits High Levels of Neutralizing Antibodies in Multiple Animal Models and Provides Protective Immunity to Mice and Nonhuman Primates , 2011, Clinical and Vaccine Immunology.

[6]  M. Graf,et al.  Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression , 2011, PloS one.

[7]  T. Tjelle,et al.  Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters. , 2008, Vaccine.

[8]  Jose P. Sterling,et al.  Extracorporeal membrane oxygenation support improves survival of patients with severe Hantavirus cardiopulmonary syndrome. , 2008, The Journal of thoracic and cardiovascular surgery.

[9]  J. Klingström,et al.  Passive Immunization Protects Cynomolgus Macaques against Puumala Hantavirus Challenge , 2008, Antiviral therapy.

[10]  V. Wahl-Jensen,et al.  Immune Serum Produced by DNA Vaccination Protects Hamsters against Lethal Respiratory Challenge with Andes Virus , 2007, Journal of Virology.

[11]  B. Hjelle,et al.  Ribavirin, human convalescent plasma and anti-beta3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model. , 2007, The Journal of general virology.

[12]  Jeffrey M. Smith,et al.  Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates. , 2006, Virology.

[13]  B. Hjelle,et al.  Neutralizing Antibodies and Sin Nombre Virus RNA after Recovery from Hantavirus Cardiopulmonary Syndrome , 2004, Emerging infectious diseases.

[14]  E. Thompson,et al.  Active and Passive Vaccination against Hantavirus Pulmonary Syndrome with Andes Virus M Genome Segment-Based DNA Vaccine , 2003, Journal of Virology.

[15]  B. Hjelle,et al.  Persistent Sin Nombre Virus Infection in the Deer Mouse (Peromyscus maniculatus) Model: Sites of Replication and Strand-Specific Expression , 2003, Journal of Virology.

[16]  Shibo Jiang,et al.  The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization. , 2002, Biochemical and biophysical research communications.

[17]  B. Hjelle,et al.  Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse (Peromyscus maniculatus). , 2002, The Journal of general virology.

[18]  C. Schmaljohn,et al.  A lethal disease model for hantavirus pulmonary syndrome. , 2001, Virology.

[19]  E. Thompson,et al.  DNA Vaccination with the Hantaan Virus M Gene Protects Hamsters against Three of Four HFRS Hantaviruses and Elicits a High-Titer Neutralizing Antibody Response in Rhesus Monkeys , 2001, Journal of Virology.

[20]  J. M. Riquelme,et al.  Genetic Diversity, Distribution, and Serological Features of Hantavirus Infection in Five Countries in South America , 2000, Journal of Clinical Microbiology.

[21]  I. Wortman,et al.  Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. , 1999, Vaccine.

[22]  F. Elgh,et al.  DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection. , 1999, Virology.

[23]  B. Hjelle,et al.  Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes , 1997, Journal of clinical microbiology.

[24]  Y. Chu,et al.  Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus. , 1996, Virology.

[25]  M. Ascher,et al.  Isolation and initial characterization of a newfound hantavirus from California. , 1995, Virology.

[26]  J. Childs,et al.  Isolation of the causative agent of hantavirus pulmonary syndrome. , 1994, The American journal of tropical medicine and hygiene.

[27]  S. Xiao,et al.  Nucleotide and deduced amino acid sequences of the M and S genome segments of two Puumala virus isolates from Russia. , 1993, Virus research.

[28]  J. Childs,et al.  Hantavirus infection--southwestern United States: interim recommendations for risk reduction. Centers for Disease Control and Prevention. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[29]  K. Yoshimatsu,et al.  Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies , 2005, Archives of Virology.

[30]  I. Takashima,et al.  Characteristics of passive immunity against hantavirus infection in rats , 2005, Archives of Virology.

[31]  C. Peters,et al.  Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. , 1999, Annual review of medicine.

[32]  G. Poste,et al.  New Generation Vaccines , 1993, NATO ASI Series.

[33]  Outbreak of acute illness--southwestern United States, 1993. , 1993, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[34]  K. Johnson,et al.  Isolation of the etiologic agent of Korean Hemorrhagic fever. , 1978, The Journal of infectious diseases.